Evaluation of the effect of spirulina extract on patients with coronavirus
Phase 3
Recruiting
- Conditions
- COVID-19.Covid-19 infectionU07.1
- Registration Number
- IRCT20200330046897N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Definitive confirmation of Covid 19 based on PCR results and approved global health clinical signs confirmed by a specialist; They are hospitalized.
Patients have informed consent to enter the study.
Exclusion Criteria
The physician's decision not to participate in the study.
The patient to be present in another clinical trial.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever. Timepoint: Daily monitoring from the beginning of the intervention to the end. Method of measurement: Thermometer.;Oxygen saturation. Timepoint: Daily monitoring from the beginning of the intervention to the end. Method of measurement: Pulse oximeter.;Dry cough. Timepoint: Daily monitoring from the beginning of the intervention to the end. Method of measurement: Physical examination,questionnaire.;C-reactive protein (CRP). Timepoint: The first day and the 7th day. Method of measurement: Blood sampling- ELISA.;Interleukin 6 (IL-6). Timepoint: The first day and the 7th day. Method of measurement: Blood Sample method: ELISA ; sensivity 0.06 pg/ml.
- Secondary Outcome Measures
Name Time Method Duration of Stay in ICU. Timepoint: Since the first day till end of stay in ICU. Method of measurement: Observation.